Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

818797

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Refugees
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will publish guidance for healthcare professionals on the entitlements refugees have to NHS treatment.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	121561
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>The Department has published extensive guidance on implementing the overseas visitor charging regulations. This guidance is for use by all frontline staff providing National Health Service funded services, as well as the providers and commissioners of those services. It is available at:</p><p><a href="https://www.gov.uk/government/publications/guidance-on-overseas-visitors-hospital-charging-regulations" target="_blank">https://www.gov.uk/government/publications/guidance-on-overseas-visitors-hospital-charging-regulations</a></p><p>This guidance, most recently refreshed in December 2017, is clear that refugees (those granted asylum, humanitarian protection or temporary protection under the immigration rules), and their dependents, are exempt from charges for NHS-funded services. They are therefore eligible for free NHS care in the same way as someone who is ordinarily resident in the United Kingdom. This guidance also sets out that any individual who has made a formal application with the Home Office to be granted asylum, temporary protection or humanitarian protection which has not yet been determined is also exempt from charges, as are their dependants, as part of the application.</p><p> </p><p>Advice and guidance for healthcare practitioners on the health needs of migrant patients, including refugees, was also published by Public Health England on 8 January 2018 and is available at:</p><p><a href="https://www.gov.uk/guidance/nhs-entitlements-migrant-health-guide" target="_blank">https://www.gov.uk/guidance/nhs-entitlements-migrant-health-guide</a></p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 11/01/2018 15:29:58 answering member 4095 label Biography information for Steve Barclay
tabling member	4433 label Biography information for Thangam Debbonaire

806629

registered interest
date	14/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of minimum unit pricing on alcohol on reducing the incidence of cancer.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	119705
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Government has made no assessment of the potential effect of minimum unit pricing (MUP) of alcohol on reducing the incidence of cancer or the number of cancer deaths. MUP and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119707 question first answered 21/12/2017 16:27:03 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

806631

registered interest
date	14/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the effect of minimum unit pricing of alcohol on the number of cancer deaths.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	119707
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Government has made no assessment of the potential effect of minimum unit pricing (MUP) of alcohol on reducing the incidence of cancer or the number of cancer deaths. MUP and its effects will continue to remain under review pending the impact of its implementation in Scotland.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119705 question first answered 21/12/2017 16:27:04 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

805975

registered interest
date	13/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of whether the UK not being part of the Clinical Trials Regulation coming into effect in 2019 will be able to take part in such trials after the UK leaves the EU.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	119185
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>In the United Kingdom, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119186 question first answered 21/12/2017 17:02:31 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

805976

registered interest
date	13/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Trials: EU Law
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the legislation that will be required in the UK to ensure that the UK becomes compatible with the EU Clinical Trials Regulation coming into force in 2019.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	119186
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>In the United Kingdom, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119185 question first answered 21/12/2017 17:02:31 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

805102

registered interest
date	12/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Rare Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health what steps his Department is taking to ensure that researchers in the UK can continue to access pan-EU patient cohorts for rare disease and other special populations after the UK has withdrawn from the EU; and if he will make a statement.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	118774
answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>The Government's policy paper, Collaboration on Science and Innovation: A Future Partnership Paper, emphasises the importance of continued collaboration with European partners to ensure that the United Kingdom remains one of the best places in the world for science and innovation. European Reference Networks for rare diseases were cited in the paper as an example of a partnership that the UK believes should continue.</p><p> </p><p>A key principle for the Government is that patients should not be put at a disadvantage as a result of European Union-exit.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/12/2017 11:50:56 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4433 label Biography information for Thangam Debbonaire

772219

registered interest
date	17/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has to assess the (a) clinical benefit and (b) value for money of Endaravone in extending the lifespan of people with motor neurone disease.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	108151
answer	answer is ministerial correction date of answer 25/10/2017 answer text <p>We have assumed the Hon. Member is referring to edaravone (Radicava). Edaravone is not currently licensed or under assessment within the European Union for any indication and the Department therefore has no such plans. If the manufacturer seeks a marketing authorisation for edaravone in the United Kingdom or EU, it will be assessed for safety, efficacy and quality through the established licensing process and then considered through the topic selection process for possible assessment of clinical and cost effectiveness by the National Institute for Health and Care Excellence (NICE).</p><p> </p><p>Where a drug or treatment has not been appraised by NICE, funding decisions should be made by the relevant National Health Service commissioner, based on an assessment of the available evidence and on the basis of an individual patient’s clinical circumstances.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/10/2017 15:57:33 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

759725

registered interest
date	12/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Benzodiazepines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what data his Department collected on benzodiazepine dependence relating to 2016.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	10122
answer	answer is ministerial correction date of answer 09/10/2017 answer text <p>Data specific to this question is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2017 11:28:10 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

751339

registered interest
date	12/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Weston Hospital: Accident and Emergency Departments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment has been made of the potential effect of the decision to close Weston General Hospital's accident and emergency department at night on the long-term staffing of that department.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	4695
answer	answer is ministerial correction date of answer 21/07/2017 answer text <p>Since the Trust Board’s decision temporarily to close Weston General Hospital’s accident and emergency department at night, North Bristol NHS Trust and University Hospitals Bristol NHS Foundation Trust (UHB) have invested in additional staff shifts in their emergency departments and medical assessment units, and UHB has increased bed numbers. Additional community resources have also been made available in north Somerset to support people in their own homes.</p><p> </p><p>Before the temporary closure, the Bristol, North Somerset and South Gloucestershire Sustainability and Transformation Plan put in place a comprehensive set of actions to mitigate the impact. These included agreeing a bespoke policy whereby patients who are expected to stay in hospital for more than 48 hours are transported back to Weston General Hospital as soon as they are deemed clinically fit enough to travel, in order to reduce the burden on neighbouring hospitals.</p><p> </p><p>Weston General Hospital is working with local general practitioners, community services, social care colleagues and neighbouring hospitals to strengthen, redesign and rebuild urgent and emergency care services in north Somerset. This includes exploring alternative staffing models for its emergency department.</p><p>By consolidating the small number of senior medical staff into daytime hours, the Trust is now able to deliver improved staff training and team building. The aim is that leadership will improve, making its emergency department a more attractive place to work. The Trust has already recruited two new consultants to work in its emergency department since the closure was announced.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 4696 question first answered 21/07/2017 09:03:45 answering member 1542 label Biography information for Philip Dunne
tabling member	4433 label Biography information for Thangam Debbonaire

751340

registered interest
date	12/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Weston Hospital: Accident and Emergency Departments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what additional resources have been allocated to accident and emergency departments in neighbouring hospitals after the decision to close Weston General Hospital's accident and emergency department at night.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	4696
answer	answer is ministerial correction date of answer 21/07/2017 answer text <p>Since the Trust Board’s decision temporarily to close Weston General Hospital’s accident and emergency department at night, North Bristol NHS Trust and University Hospitals Bristol NHS Foundation Trust (UHB) have invested in additional staff shifts in their emergency departments and medical assessment units, and UHB has increased bed numbers. Additional community resources have also been made available in north Somerset to support people in their own homes.</p><p> </p><p>Before the temporary closure, the Bristol, North Somerset and South Gloucestershire Sustainability and Transformation Plan put in place a comprehensive set of actions to mitigate the impact. These included agreeing a bespoke policy whereby patients who are expected to stay in hospital for more than 48 hours are transported back to Weston General Hospital as soon as they are deemed clinically fit enough to travel, in order to reduce the burden on neighbouring hospitals.</p><p> </p><p>Weston General Hospital is working with local general practitioners, community services, social care colleagues and neighbouring hospitals to strengthen, redesign and rebuild urgent and emergency care services in north Somerset. This includes exploring alternative staffing models for its emergency department.</p><p>By consolidating the small number of senior medical staff into daytime hours, the Trust is now able to deliver improved staff training and team building. The aim is that leadership will improve, making its emergency department a more attractive place to work. The Trust has already recruited two new consultants to work in its emergency department since the closure was announced.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 4695 question first answered 21/07/2017 09:03:45 answering member 1542 label Biography information for Philip Dunne
tabling member	4433 label Biography information for Thangam Debbonaire